Phase 2 × Inflammatory Breast Neoplasms × Docetaxel × Clear all Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
Phase 2 Completed
105 enrolled 17 charts
NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer
Phase 2 Completed
41 enrolled 10 charts
PROMIX
Phase 2 Unknown
151 enrolled
Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
Phase 2 Terminated
5 enrolled 6 charts
Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
Phase 2 Completed
45 enrolled
NACprotocol
Phase 2 Unknown
60 enrolled
Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Phase 2 Terminated
34 enrolled 9 charts
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
Phase 2 Unknown
94 enrolled